Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroid for Hip Osteoarthritis Pain
NCT06793982Phase 4Recruiting
- Sponsor
- LifeBridge Health
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of platelet-rich plasma in hip osteoarthritis (2 arms), sponsored by LifeBridge Health. Primary endpoint: Visual Analog Scale for Pain at 3 months. Started Feb 2024; status: recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT06793982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06793982.